Dyskeratosis congenita, also known as Zinsser-Engman-Cole syndrome, is a rare progressive congenital disorder with a highly variable presentation. It was classically defined by a triad of abnormal skin pigmentation, nail dystrophy and leukoplakia of the lining of the mouth, together with myelodysplastic syndrome or acute myeloid leukemia, although these features do not always occur together. The disease is characterized by short telomeres. It often first shows in the skin, but its most serious consequence is progressive bone marrow failure, which occurs in more than 80 percent of people affected and causes early death.
Facts
Classification
ICD-10 ChapterXVII: Congenital Malformations, Deformations and Chromosomal Abnormalities 2 Communicable or Non-communicable Causative Agent
Causative Agent (category) Sources
1. Dyskeratosis congenita (Wikipedia)
Lead paragraph
The disease initially can affect the skin
Lead: disease category
Dyskeratosis congenita (DKC), also known as Zinsser-Engman-Cole syndrome, is a rare progressive congenital disorder with a highly variable phenotype.
Article text
Mutations in Nop10, Nhp2 and dyskerin1 have all been shown to lead to DKC-like symptoms.
View the Source2. World Health Organization ICD-10: ICD-10 Version:2019 - Q80-Q89
World Health Organization ICD-10Category Q82.8Quote, Category Q82.8
Q82.8 Other specified congenital malformations of skin
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.